Steven Almany — BioStar Ventures
Dr. Steven Almany is a partner with BiostarVentures (www.biostarventures.com) a Michigan based venture firm engaged in the development of medical devices. He is vice-chief of cardiology at William Beaumont Hospitals and is board certified in internal medicine, cardiology, and interventional cardiology. He holds several patents in the field of cardiovascular medicine. He has authored over 69 articles and book chapters in the field of cardiovascular medicine.
Mostafa Analoui – The Livingston Group
Mostafa Analoui, Ph.D., is Head of Healthcare and Life Sciences at The Livingston Group (New York, NY). Previously he was the Senior Director at Pfizer Global Research and Development. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies.
While at Pfizer, he was the Site Head for Global Clinical Technology in Groton and New London, a division focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Dr. Analoui was the Director of Oral and Maxillofacial Imaging Research, Associate Professor of Radiology at Indiana University, and Associate Professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. He has received his Ph.D. from Purdue University, followed by Post-Doctoral Fellowship at IBM TJ Watson Research Center in NY. In addition to industry leadership in biomedical and technology fields, he consults and lectures in US, Europe and Asia. He has also served on various scientific, regulatory, and business advisory committees and boards, including NIH, NSF, PhRMA, NASA, and OECD. Dr. Analoui has authored over 130 publications, including journal articles, book chapters and technical reports. He is senior member of IEEE, SPIE, and RSNA.
Ananth Ananthasubramaniam — DTE Energy
Ananth Ananthasubramaniam joined DTE Energy in 1995, and leads DTE Energy Venture’s investments. He has been on the board as a director or an observer of a number of portfolio companies. Prior to joining DTE Energy, Ananth was a management consultant with Booz Allen Hamilton and EDS. Ananth has a B.S. in Mechanical Engineering from IIT Madras, an M.S. in Industrial Engineering from the University of Florida, and an M.B.A. from the Kellogg School of Management at Northwestern University.
Mark Arizmendi – Northwestern Capital Partners
Mark Arizmendi founded Northwestern Capital Partners, LLC in 2001. Mark has served as a board member of several client firms in the health-care and real estate industries. Currently, he is acting as Managing Director for HealthCure, LLC, one of Northwestern Capital’s portfolio companies. Prior to 2001, Mark started and developed a real estate and construction firm. He attended the University of Southern California as an Economics major and California Merit Scholar, and received an MBA from Queens University (McColl School of Business) and attended a year-long executive program at the Kellogg Graduate School of Management at Northwestern University. Mark is involved with the Michigan Twenty First Century Jobs Fund and spoke at the 2010 MichBio conference. Mark serves on several non-profit boards, including the Leukemia Lymphoma Society, the USC Board of Ambassadors, the Mecklenburg Area Catholic Schools Foundation, and is active with Girls on the Run-Chicago. In his time away from NCP, Mark enjoys surfing, swimming, reading, and enjoying active family pursuits in Idaho, North Carolina, and the Midwest.
Lindsay Aspegren — North Coast Technology Investors
Lindsay Aspegren is a co-founder and general partner of North Coast Technology Investors, LP, a venture capital firm which was founded in 1999 with $135 million in capital under management. Mr. Aspegren is an active founder and investor in early stage companies including Chromatic Research, Inc., Virtela Technology Services, Inc., Gema Diagnostics, Inc. and Fulcrum Composites, Inc., among others. Mr. Aspegren is a graduate of Yale University and the London School of Economics where he earned a B.A. in Economic History. He received his M.B.A. from the Harvard Business School.
Jeff Barry — Plymouth Ventures
Jeff is a partner with Plymouth Management Company (PMC) the manager for Plymouth Venture Partners I and II. He is involved in the management of both funds. His duties include sourcing, evaluating and negotiating deals; as well as monitoring and adding value to the current portfolio. Prior to his work with PMC, Jeff was a Senior Economist at the Overseas Private Investment Corporation (OPIC) in Washington, DC where he was responsible for evaluating financing proposals from small– and medium-sized businesses, as well as Fortune 500 companies, and determining suitability of the transactions. OPIC functions as a commercial bank, financing high-risk private investment in emerging markets. Jeff also managed the downstream monitoring of OPIC investments.
Jeff began his career as an International Finance Consultant, spending ten years with Coopers & Lybrand/ PricewaterhouseCoopers and Stone & Webster Management Consultants, where he managed and actively participated in projects involving asset sales and sell-side privatization transactions in Latin American, Africa, and Asia, in sectors ranging from coffee farms to electricity generation to cellular telephony. Jeff holds an MBA in Finance from Vanderbilt University and a BA from Trinity College in Economics.
Hugo Braun — North Coast Technology Investors
Hugo has been an active venture capital investor in the Midwest and California since 1987. Hugo has evaluated hundreds of investment opportunities per year, acted as lead investor in both equity and subordinated debt investments, and has served on the boards of directors of public and private companies.
Prior to founding North Coast, Hugo was a partner in Access Ventures, a Michigan based investment firm with over $30 million under management. In addition, Hugo has co-managed BankAmerica Venture Capital’s $100 million venture portfolio. Investments included computer hardware and software, semiconductors, medical devices, telecommunications and retail.
Mike Bunker — Early Stage Partners LP
Mike has many areas of expertise but has recently focused a lot of time on the treatment of stroke and on catheter-related technologies, particularly those that reduce the incidence of nosocomial infection. Among Mike’s investments are Juventas Therapeutics, Cardiox, Histosonics, Great Lakes Pharmaceuticals, and CytoPherx. Prior to joining Early Stage Partners as Managing Director in 2008, Mike held roles in sales management and corporate acquisitions for C.R. Bard Access Systems (NYSE: BCR). As Director of Corporate Development, he created the process to evaluate medical technology investments for Bard’s six centralized divisions and successfully executed 14 acquisitions, licenses, and divestitures. Later, Mike managed a field sales force and negotiated multiple contracts with hospitals.
Mike joined Medtronic (NYSE: MDT) in 1998 where he initially led a $750 million global product launch in cardiac rhythm management and served on product development, strategy and clinical committees. Mike then served in Medtronic’s corporate development group, closing over ten minority investments and acquisitions in support of corporate strategy initiatives across the neurostimulation, cardiac rhythm management, orthopedic and vascular business units.
Mike also served in sales and marketing management roles earlier in his career for Apogee Enterprises and Rand McNally. Mike is a graduate of Miami University (B.S.) where he studied Marketing, and the Kellogg Graduate School of Management at Northwestern University (M.B.A.).
Neil Cameron — Emerald Technology Ventures
Based in Emerald’s Toronto office, Neil Cameron’s sector expertise is in the field of advanced materials and processes. In the Emerald Portfolio, Neil serves as a Board Observer for TerraLUX, is on the technical advisory board of SDC Materials and supports Emerald & management at ARXX, Xunlight and Azzurro in various Board committees. Prior to joining Emerald in 2006, Neil was a project leader and staffscientist with the National Research Council of Canada (IndustrialMaterials Institute), was a Research Associate at McGill University and has consulted on technical and IP issues. Recent projects have includedwork in nanotechnology, high-fidelity micro– & nanofabrication, polymersynthesis & applications, interfacial interactions and he is the co-inventor of a patented water-purification resin. Neil holds a Doctorate in Chemistry from McGill University and a Bachelor of Science in Chemistry and Biochemistry from the University of King’s College(Dalhousie University).
Louis Cannon — BioStar Ventures
Dr. Cannon is a former Judith Volkman Scholar In Residence, and is the Founder and Senior Managing Director of BioStar Ventures. He has been repeatedly honored as one of “America’s Top Interventional Cardiologists”, is the President of the Cardiac and Vascular Research Center of Northern Michigan, and has over hundreds of medical publications, as well as United States medical device patents. He has or does serve on the strategic advisory boards for such Fortune 500 companies as Medtronic, Abbott, and Boston Scientific, JNJ, Covidien, as well as many early developing medical technologies. He currently serves on the Board of Directors of CardioVascular Ingenuity and Kona. Dr. Cannon, through BioStar, has participated in the start up and subsequent development of a multitude of developing bio-technological, or emerging healthcare companies and has served as the National or International Principal Investigator for landmark cardiovascular studies. Dr. Cannon assisted in performing First-In-Man percutaneous Aortic Valve procedures in Paraguay in 2007 and served as Chairman of the Board of AorTx, Inc, which was successfully acquired by a publicly traded company. Similarly, BioStar was also the lead investor of Setagon, whereby Dr. Cannon served as the Chairman of the Scientific Advisory Board, which was also acquired by a Fortune 100 company.
Carolyn Cassin — Belle Capital
Ms Cassin is a co-founder & co-Manager of ‚BELLE Capital Management, LLC, the General Partner. Ms. Cassin is the president and chief executive officer of the Michigan Women’s Foundation, a Michigan non-profit corporation, which has been championing the causes of social justice for women and girls through public and private education, philanthropy and advocacy for over 20 years. In addition, she is president and chief executive officer of National Hospice Work Group, a CEO think tank for executives of the largest Hospices in the US. Prior to joining the Michigan Women’s Foundation, Ms. Cassin was a nationally recognized healthcare executive and turnaround specialist for almost 30 years. In 1988, after two years as chief executive officer of Hospice of Southeastern Michigan, she retired their debt and maintained profitability throughout her tenure, growing the company over 10 years to over $50 million in revenues and 1,000 employees, with seventeen sites which ultimately earned Hospice of Michigan the award of “Best Managed Non Profit” by Crain’s Detroit. In 1998 she was recruited to VistaCare, a venture capital backed national hospice company, based in Phoenix, Arizona. As VistaCare’s Chief Operating Officer, Ms. Cassin merged 48 sites into one company and built the company from $3 million in revenues to $100 million and positive EBITDA. Most recently, Ms. Cassin served as chief executive officer of Continuum Health Partner’s New York City Hospice program, building it into the largest hospice in New York City with revenues of over $50 million. Ms. Cassin has received numerous national awards from the first National Hospice Organization’s Heart of Hospice Award, to the Founders Award from that same organization. She has served as President of the National Hospice and Palliative Care Organization and on its Board. Most recently she was named a “Woman to Watch” by Crain’s Detroit Magazine in 2009.
Elizabeth Charnock — Cataphora
Elizabeth founded Cataphora and has led it from concept to successful profitability and to a successful pre-IPO divestiture that is unprecedented in the history of bootstrapped Silicon Valley software startups. To do this, she has drawn on her prior experience as a CEO and on her extensive knowledge of information retrieval technology and business. She was CEO and founder of Troba, an industry leading Customer Relationship Management software company which she sold in 2001. Elizabeth has significant experience in engineering management, management consulting, and restart management at such companies as Hewlett-Packard and Sun Microsystems. Elizabeth holds a BS in Theoretical Mathematics from the University of Michigan Honors Program.
Paul Cummings — Honda Research Institute
Paul Cummings is Head of the Honda Research Institute Fundamental Technology Partnering group based in Mountain View, California. Honda’s competitive advantage has always come from product innovation supported by strong R&D activities. Together with Honda’s Fundamental Technology Research areas, our mission is to identify trends in innovation, scout technology partners to fulfill various long-term needs of Honda’s Fundamental Technology Research efforts, and convert ideas into realizable collaborative projects. Technology areas of interest include Alternative Energy, Advanced Materials, and Intelligent Machine Technologies. Prior to joining Honda, Paul held various management positions with automotive tier 1 supplier Delphi; including positions in mergers and acquisitions, business development and operations for a Japanese partnered joint venture. Paul also worked for Accenture in the Sydney, Australia office with the Strategy Consulting Practice. Paul holds an MBA from the University of Chicago, and BA from Michigan State University.
Nick Darby — Rho Ventures
Nick Darby is a venture partner of Rho Ventures. A founding member and director of more than 12 years at the Corporate Venture Capital Group at Dow Chemical, he brings considerable expertise in new business development and evaluating and shaping nascent companies for venture investing.
Nick joined Rho in 2009 and focuses on investments in energy and related technologies. At Dow Chemical, he was responsible for numerous investments in corporate spin-outs and university-based start-up companies, primarily in the physical sciences. Prior to the Dow VC Group, he was an executive in Dow Chemical Canada’s research and development and in corporate new business development. He directed programs in numerous industries and diverse markets, such as energy generation, advanced materials and electronics (including information displays, data storage, compound semiconductors, organic electronics and packaging/interconnect).
Nick received post-doctoral training at the University of British Columbia and was a fellow at University College, London. He holds a Ph.D. from the University of Alberta and a B.Sc. with honors from Queen’s University, Canada. He is currently a board member at MaRS Innovation, an innovative approach to commercializing technology from the major Toronto research institutions. He also serves as an investment reviewer for the State of Michigan Pre-Seed Fund.
Rob Day — Black Coral Capital
Rob Day is a Partner with Black Coral Capital, based in Boston. He has been a cleantech private equity investor since 2004, and acts or has served as a Director, Observer and advisory board member to multiple companies in the energy tech and related sectors, currently including Digital Lumens, Next Step Living, and Powerit Solutions.
Rob serves as the Chairman of the Cleantech Open – Northeast Region. Rob was previously a co-founder of the Renewable Energy Business Network, a non-profit organization which was acquired in 2009 by the Clean Economy Network. Since 2005 he has also authored the website Cleantech Investing, which currently appears on GreentechMedia.com.
Formerly a consultant with Bain & Company, Rob has worked with companies and evaluated private equity transactions in the energy/ utilities, telecom, IT, medical/pharmaceutical, and retail industries. Earlier in his career, Rob was a member of the World Resources Institute’s Sustainable Enterprise Program, where he co-authored the report The Next Bottom Line: Making Sustainable Development Tangible. Rob received his MBA at the Kellogg Graduate School of Management (Northwestern University), and his BA at Swarthmore College.
Keith Gillard — Pangaea Ventures
Keith Gillard is General Partner at Pangaea Ventures, an industry leader in early stage advanced materials investment. Keith has twenty years’ experience with the past ten years focused on cleantech and advanced materials. From 2006–2010, Keith served as President of BASF Venture Capital America, establishing the Silicon Valley office and leading several investments. From 2001–2006, Keith was with Mitsubishi Corporation and responsible for investment activities in Canada, with a focus on cleantech. Prior to joining Mitsubishi, Keith began his career in investment banking and spent the late ‘90’s as an entrepreneur.
Keith is a member of the C100, Californian Consortium on Green Chemistry and the Synthetic Biology Industry Association. He is the co-author of “Inside the Minds: Energy Venture Capital Best Practices”, published in 2008 by Aspatore Books. Outside of work, he is the high-energy father of two, an avid cyclist and a Canadian Independent Music Award winner.
Patti Glaza – Arsenal Venture Partners
Patti Glaza is a Principal at Arsenal Venture Partners and balances her time between investment identification and evaluation, portfolio development, and helping support the entrepreneurial community. She has spent over twenty years dedicated to the development, implementation and commercialization of advanced technologies. Patti currently sits on boards for the Clean Coalition, The University of Michigan WIMS Center, and CTSI, where she chairs the organization’s annual defense and utility technology challenges. Prior to joining AVP, Patti served as a Founder and the Executive Director/CEO of the Clean Technology and Sustainable Industries Organization (CTSI). She worked closely with government agencies including the Department of Defense and Department of Energy/ARPA-E, multinational corporations and utilities, and start-ups to identify and promote leading-edge technology solutions in energy, water, and overall sustainability. After several start-ups, Patti lead Small Times, a global media group focused on micro, MEMS, and nanotechnology commercialization. She started off her career as an IT/operations consultant and manager at Accenture. Patti is a graduate of Michigan State University with a BA in International Relations and Economics, and has her MBA from the University of Michigan, Ann Arbor. In addition to juggling ‘Go Green’ and ‘Go Blue’, Patti likes to run and do any sporty activity (preferably someplace warm) that helps her keep up with her husband and two spirited daughters.
Dale Grogan — Michigan Accelerator Fund 1
In his over 20 years of professional business expertise, Dale Grogan has been an entrepreneur and an investment banker. For start-up and early stage companies, he has raised over $15 million.
Grogan has started and owned numerous businesses, including an NASD broker/dealer firm (Stanley Grogan Investments), several technology companies, and consulting firms focused on start-up businesses (Acuity Capital Management, Acuity Capital Partners). He was the founder and CEO of a high-tech, Leapfrog Smart Products, which he took public, and then private again. In terms of technology competence, Dale was an original member of the GSA Interoperability Standards Committee for the development and usage of smart card applications within the federal government. Grogan is currently a Board Member of the Smart Card Alliance, the smart card industry’s non-profit trade association, as well as serves as Secretary of the Healthcare Steering Committee.
Grogan sits on the Board of SMART Association, Inc., the nation’s leading smart card solutions provider in the healthcare market and EyeSupply USA, a niche ophthalmic supply business. As it relates to Michigan entrepreneurial activities, Grogan is a member of the “Michigan Pre-Seed Investment Fund” Investment Review Board (since 2008), responsible for vetting business plans for investment by the Fund, has been a judge for the Great Lake Entrepreneurial Quest (since 2007), and a judge for the ACG Cup (since 2009) an MBA business student competition analyzing advanced business case studies. Grogan attended Huntington College in Montgomery, AL where he studied chemistry and biology and was granted early admission to the University Of Alabama School Of Optometry in Birmingham, AL, where he studied general optometry and physiological optics.
Sandeep Jain – Abu Dhabi National Energy Company (TAQA)
Sandeep has about 15 years of experience in the business development and finance areas in the energy industry. He is currently the Head of Renewable Energy for his company, the Abu Dhabi National Energy Company, and responsible for building an international portfolio of assets of about $ 2.0 billion value over the next 5 years. Prior to this he has managed business development in North America and India for his company. Sandeep also served on the Board of Directors and as asset manager for a 250 MW power plant in India with responsibility for all key commercial decisions.
In the past, he has also been involved in new project development as well as in acquisition and divestiture of operational assets. He helped his previous company, CMS Energy, sell a couple gas pipelines in Australia and then helped them grow by acquiring a gas-fired power plant in Michigan. He was also involved in the green-field development of a 1600 MW coal-fired power plant in Northern Illinois. He started his career as an investment banker project financing the early power, telecom and other infrastructure projects in India..
Abdul Jarrar — Intel
Abdul Jarrar is one of Intel’s leading emerging markets experts. A 14-year veteran of the company he currently directs the corporation’s Emerging Markets Product strategies aimed at accelerating Intel’s growth in those markets. Previously he served as Chief of Staff to the Chairman of the Board Dr. Craig Barrett where he was responsible for directing the Chairman’s engagements worldwide as well as playing a pivotal role in defining and steering Intel’s growth strategies. Over the past 17 years, Abdul’s career spanned a variety of technical, marketing and management roles. He lead Intel’s Strategic Growth Office in Europe, Middle East, and Africa as well as the Corporate Affairs Group for the Middle East, Turkey and Africa where he was responsible for Intel’s engagements with governments in the region, policy advocacy for technology access, broadband deployment, and education programs. While based in Dubai from 2004 to 2007, Abdul played a pivotal role in the expansion of Intel’s investments in the region including the creation of a $50M fund with focus on startups in the region. He also represented the ICT industry on the board of the multimillion dollar UAE ICT R&D Fund. Prior to joining Intel, Abdul held a range of positions with American Megatrends Inc., where he established the company’s operations in Taiwan.
Gretchen Knoll — Lake Street Capital, LLC.
Ms. Knoell is the Founder and Managing Member of Lake Street Capital, LLC. Prior to founding the Firm in 2003, Ms. Knoell spent 18 years primarily in investment banking and corporate development, focused on the communications services, software and related equipment, and healthcare IT sectors. During that period, Ms. Knoell served as Vice President of Business Development at Digital Island Corporation, Senior Managing Director of Corporate Finance co-heading the West Coast Technology Group at Bear Stearns & Co., Inc., as well as Head of Corporate Finance at Punk, Ziegel & Knoell, a specialty investment bank committed to emerging growth companies which she co-founded in 1990. During her career as a banker, Ms. Knoell led the successful completion of billions of dollars of IPOs and mergers and acquisitions. Ms. Knoell started her investment banking career in 1985 with Needham & Company. Prior to attending business school, Ms. Knoell was an engineer with Exxon Corporation.
Ms. Knoell received her M.B.A. from Harvard University Graduate School of Business Administration, and a B.S. in Mechanical Engineering from Cornell University.
Ms. Knoell currently serves Cornell University as a Member of the Engineering College Advisory Council. She is also a Trustee of University Liggett School.
Ms. Knoell currently serves on the board of directors of Silicon Genesis Corporation and serves as a Board Observer of SportVision, Inc. Previously Ms. Knoell served on the boards of Celion Networks, Inc., Frictionless Commerce, Inc., Lucid Media, Inc., Network Elements, Inc., Nufern and Sequence Design, Inc. and served as a Board Observer of Core Networks, Inc., PartMiner, Inc. and VeriCenter, Inc.
Rajesh Kothari — Seneca Partners
Raj Kothari draws on over two decade of experience as an investor, a financial advisor, and an entrepreneur. He is a co-founder and Managing Director of Seneca Partners, a private investment and investment banking firm where he assists companies with mergers, acquisitions, divestitures and other corporate finance activities. In addition, Seneca Partners makes are variety of control and non-control investment in companies in the business service, high value manufacturing, technology, and healthcare sectors.
Raj co-leads the firm’s investments in emerging healthcare companies through Seneca Health Partners, a venture capital fund dedicated to emerging healthcare companies. Prior to founding Seneca Partners, he was a Director at Beringea (formerly GMA Capital), a boutique investment-banking and venture capital firm where he led numerous divestitures, recapitalizations, acquisitions and other strategic transactions for clients in a variety of industries. In addition, he co-managed the firm’s $70 million healthcare private equity fund, InvestCare Partners. Raj has also served as an Investment Officer for ProVen Private Equity in London, England, a venture capital affiliate of Beringea. He began his investment career as a money manager, most prominently for Masco Corporation where he was responsible for a portfolio of $130 million in pension assets. He left Masco to found Cranbrook Capital Management, a $650 million money management firm, where he was Treasurer and Director of International Investing.
Raj serves on the Board of Priority Health, Micro Machine Company, LLC, MedBio, Inc., Providence Health Foundation, and the CAP Foundation as well as a board observer for Critical Signal Technologies and RedPath Integrated Pathology. He sits on the Investment Committee for Automation Alley, Civil Air Patrol, and the Finance Committee for Priority Health, and St. John Providence Health System. Raj was honored as one of Crain’s Detroit Business’s 40 Under 40 honorees and is a Lieutenant Colonel in the Civil Air Patrol in which he has served for over 30 years. Raj is also an Adjunct Instructor at the University of Notre Dame. Mr. Kothari, a CFA, earned a BA and MBA from the University of Michigan.
Frank Legacki — Fletcher Spaight Ventures
Frank Legacki has over 35 years of experience in private equity and consulting. Frank works out of Fletcher Spaght Ventures satellite office in Ann Arbor, Michigan. Previously, Frank was Senior Vice President and a founding investor of Rosebud Solutions until its acquisition by McKesson. Prior to Rosebud, he worked as President and CEO of Kaepa, a high performance athletic footwear company that focused on niche athletic footwear markets. Frank led the LBO of Kaepa from Wolverine World Wide, and sold the company to Umbro. Frank has also held positions as President of the Andover Consulting Group, Vice President of Marketing at Converse, and Managing Director of The Strategic Consulting Group of Marketing Corporation of America.
Frank received his BA and MBA from the University of Michigan in Ann Arbor, MI. As a former varsity swimmer at the University of Michigan, Frank was a five time national champion and captained the 1961 U of M National Championship team. He was inducted into the U of M Athletic Hall of Honor in 1995. He is an active member of the U of M community, serving on the Board of Directors of the University’s Alumni Association and was a previously a board member of the University’s Urology Center, Letterwinners M Club and President of the Grey Whales.
Scott Livingston – The Livingston Group
Scott Livingston is a Managing Director of Axiom Capital Management Inc. (Axiom) and head of the Livingston Group, an investment and corporate advisory group within Axiom focused on nanotechnology. Axiom Capital Management Inc. provides wealth management, investment banking, prime brokerage and private equity services. Mr. Livingston has been called “sharp and highly connected” by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been an invited speaker on nanotechnology investment trends at the Harvard Club, the Nanobusiness Alliance, the Cambridge Healthtech Institute, Nanotechnology.com, the International Business Forum, the Delaware Technology Park, the Business Executives for National Security, Hilary Clinton’s Jobs for New York, and has presented to half a dozen state pension leaders across the country. Scott is also the creator of the annual Axiom Capital Management “Livingston Nanotechnolgy Conference”, one of the largest nanotechnology conferences of the year.
Previously, Scott has served as a Senior Vice President – Investment Management at Lehman Brothers, where he began his nanotechnology focus. Prior to joining Lehman Brothers in 2000, Scott was a Director of the Private Client Group at SG Cowen Securities, and prior to that was at Drexel and Smith Barney. Scott is a SUNY Albany graduate. He is a board member of the NanoBusiness Alliance and a founding board member of the NY Nanobusiness Alliance. Scott sits on the board of the Nanoethics Group and the Dolan DNA Learning Center at the Coldspring Harbor Labs. He is married with three children and lives in Long Island, NY.
Eddie Martucci — PureTech
Dr. Martucci is a Senior Associate at PureTech Ventures, and is part of the founding team of Akili Interactive Labs, Appeering, and Vedanta Biosciences. He was previously a Kauffman Entrepreneur Fellow, a program sponsored by the Kauffman Foundation.
Dr. Martucci completed his graduate work at Yale University in the Departments of Pharmacology and Molecular Biophysics & Biochemistry, focusing on the rational design of novel allosteric inhibitors for a pathogenic parasite. He led a research project that characterized a potential enzyme drug target and identified two novel chemical scaffolds as potent proof-of-concept compounds for novel antiparasitic therapy. During his graduate work, he received NIH training grants in both Chemical Biology and Parasitology.
Dr. Martucci received his B.S. in Biochemistry from Providence College, and his M.Phil. and Ph.D. from Yale University.
Ken Massey – LifeLine Ventures
Kenneth D. Massey is the Managing Director for Micro Dose Life Sciences, LLC and the associated venture capital fund for LifeLine Ventures, LLC. He has 26 years of biomedical research experience in academic and pharmaceutical and biotech arenas. Prior to joining Micro Dose, his served as a Director of Clinical Development for Pfizer, Inc. and Assistant Professor, with a joint appointment in Anesthesiology and Pharmacology, in the University of Michigan Medical School. Massey holds a Bachelor’s of Science from Eastern Michigan University and a Ph.D. in cardiovascular pathophysiology from the University of Texas.
Sajjad Masud — Harvard Angels
Sajjad is an entrepreneur and a consultant and advisor to startups, as well as an angel investor and member of the Harvard Angels group. Sajjad is passionate about working with entrepreneurs, and in helping and guiding them through different phases of a startup’s growth lifecycle. As an executive, Sajjad has over 15 years of marketing and strategy leadership experience in the software, internet & technology-enabled services space. An out-of– the-box thinker with an entrepreneurial spirit and a well-balanced combination of deep business insights, strategic thinking and technology expertise, Sajjad brings proven leadership skills in identifying a growth opportunity and then helping and organizing high-caliber teams to strategize, collaborate, and deliver on that opportunity. Sajjad was founder & CEO of Apvision, a software & services company providing compliance-enabling business solutions to the financial services sector.
Jeff Maters – New World Ventures
Jeff is a Senior Associate at New World Ventures, a multi-stage venture capital firm based in Chicago. He joined New World Ventures in 2008 and focuses on identifying and helping build high potential software and internet companies. Jeff currently serves as a board observer at SinglePlatform.
Jeff was previously with UBS Investment Bank’s Midwest Group, where he advised clients on a broad range of corporate finance and M&A transactions. Prior to UBS, Jeff was with BMV Capital, a venture capital firm focused on early stage technology, communications and media companies. Prior to BMV, Jeff was with the Lehman Brothers Communications Fund, an $800 million venture capital fund focused on the communication services sector. Jeff graduated with a B.S. in chemical engineering from the Johns Hopkins University and earned his M.B.A. with High Distinction from the Stephen M. Ross School of Business at the University of Michigan.
Bret Maxwell – MK Capital
Bret is a Managing General Partner at MK Capital. He is also the Managing General Partner on three of the Productivity Funds totaling $200 million in committed capital. Bret has been a decision-making partner in six other fully invested funds, representing over $300 million in committed capital. Prior to founding MK Capital, he was the co-Founder of First Analysis’ venture capital practice in 1985. Bret’s areas of expertise include outsourced business services, telecom and internet infrastructure, and energy and power infrastructure. Bret is a graduate of The McCormick School of Engineering at Northwestern University and Kellogg’s Graduate School of Management. He has served as the Chairman of the Illinois Venture Capital Association, and is a director on the board of Mount Sinai Hospital and on the finance committee of the Jewish United Fund. He is also Certified Financial Analyst.
Andrew McColm – Early Stage Partners
Andrew leads the Michigan office of Early Stage Partners, a Midwest focused venture capital fund. His broad and deep industry experience and knowledge of technology enables him to cover all of ESP’s investment sectors.
Andrew joined Early Stage Partners as Managing Director in October 2009, coincident with the firm’s entry into Michigan. Prior to joining ESP, Andrew was Associate Director — Business Formation, for the University of Michigan Office of Technology Transfer. During his tenure at UM, he was involved in the formation of over three dozen technology based companies across a range of industries from software and materials to medical devices. Andrew also developed a national network of venture capital investors to review university opportunities. Over the preceding twenty years, Andrew was an executive or key manager in multiple international telecommunications startup companies in the United States, U.K, and Brazil.
Paul McCreadie — Arboretum Ventures
Paul McCreadie joined Arboretum Ventures in 2006 and is responsible for sourcing and leading new investments in promising healthcare companies. He led Arboretum’s investment into Delphinus Medical Technologies and Wellfount Pharmacy and currently serves on the Board of Directors of each company. Paul has also been a board observer at VasoNova (acquired by Teleflex) and NeoGuide. He is the former Chief Operating Officer for CerviLenz, a portfolio company based in Ohio, where he led the re-design of the company’s first commercial product from concept to launch.
Prior to joining Arboretum in 2006, Paul worked at Ford Motor Company for eight years, holding management positions within new product development, manufacturing, and business strategy. He was a member of the Wolverine Venture Fund (WVF) while an MBA student at Michigan’s Ross School of Business. Paul was the fund’s liaison with IntraLase, one of the WVF’s most successful investments to date, which was acquired by American Medical Optics in 2007. Paul earned a BS and MS in Mechanical Engineering from the University of Michigan and an MBA from the Ross School of Business at the University of Michigan.
Kevin McCurren — GVSU
J. Kevin McCurren joined the Center for Entrepreneurship & Innovation in May 2011 as the Exectuvie Director. Kevin has over 25 years of combined corporate and entrepreneurial experience. As an entrepreneur he has been involved in the start-up of a medical management company, a dental laboratory company and several biomedical companies. As an investor, Kevin has been involved in several angel investment groups and recently served on the Executive Committee of the Venture Club of Louisville. Kevin holds a Bachelor of Science and Masters Degree in Public Health and Health Services Management from the University of Missouri
Pat Morand – Southwest Michigan First Life Science Fund
Pat Morand is Managing Director of the SWMF Life Science Fund, headquartered in Kalamazoo, Michigan. The SWMF Life Science Fund is the nation’s only community-based venture fund. With $65 million under management, Pat is responsible for sourcing all potential investments, leading them through the fund’s stringent due diligence process and overseeing the fund’s portfolio company management teams. Prior to joining the fund, Pat was a three-time Chief Executive Officer in the biologics industry; Vice President of Commercial Operations for Genesis Therapeutics; Executive Vice President of Sequitor Medical Technologies; and Executive in Residence of the Pittsburgh Life Sciences Greenhouse, a public/private investor in regional life sciences companies where he provided executive support to over 65 companies, representing $100 million of investment and 121 employees.
Gretchen Knoell – Lake Street Capital
Ms. Knoell is a Partner with Lake Street Capital. Prior to founding the Firm in 2003, Ms. Knoell spent 18 years primarily in investment banking and corporate development, focused on the communications services, software and related equipment, and healthcare IT sectors. During that period, Ms. Knoell served as Vice President of Business Development at Digital Island Corporation, Senior Managing Director of Corporate Finance co-heading the West Coast Technology Group at Bear Stearns & Co., Inc., as well as Head of Corporate Finance at Punk, Ziegel & Knoell, a specialty investment bank committed to emerging growth companies which she co-founded in 1990. During her career as a banker, Ms. Knoell led the successful completion of billions of dollars of IPOs and mergers and acquisitions. Ms. Knoell started her investment banking career in 1985 with Needham & Company. Prior to attending business school, Ms. Knoell was an engineer with Exxon Corporation.
Ms. Knoell received her M.B.A. from Harvard University Graduate School of Business Administration, and a B.S. in Mechanical Engineering from Cornell University.
Ms. Knoell currently serves Cornell University as a Member of the Engineering College Advisory Council. Ms. Knoell also serves on the board of directors of Lucid Media, Inc. and Silicon Genesis Corporation, and serves as a Board Observer on PartMiner, Inc. Previously Ms. Knoell served on the boards of Celion Networks, Inc., Frictionless Commerce, Inc., Network Elements, Inc., Nufern, and Sequence Design, Inc. and served as a Board Observer of Core Networks, Inc. and VeriCenter, Inc. All of the above mentioned companies are or were LSC portfolio companies.
Dov Rosenberg — Allos Ventures
Dov is a Director at Allos Ventures and Blue Chip Venture Company, where he enjoys helping entrepreneurs change markets through the application of new technologies. He also manages Blue Chip’s Validation Fund, which has invested in nine seed– and startup-stage technology companies over the past five years.
Before beginning his venture capital career with Blue Chip in 2005, Dov served on the management team at a privately-held manufacturing company, was a senior strategist in the Intellectual Property Strategy and Development group of Battelle Memorial Institute, and developed and managed the deployment of software as an IT consultant for Cap Gemini.
David Ruby — Beringea
David Ruby is responsible for investment sourcing, analysis, deal execution and portfolio management. David serves as a board director for Beringea portfolio company Livio Radio.
Prior to joining Beringea, David was an analyst with P&M Corporate Finance (PMCF), a middle-market investment bank in Chicago. While at PMCF, David executed M&A transactions for companies in the business services and life sciences industries. Before working at PMCF, David was an associate portfolio manager with the Northern Trust Company, a global asset management firm in Chicago.
David holds an MBA from the University of Michigan’s Ross School of Business and a BBA from Western Michigan University. He is also a CFA charterholder.
Tim Streit — Huron River VC
Tim has over 10 years of operating, investing, and financing experience, including corporate venturing and as an “intrepreneur”, where he commercialized disruptive new high-tech consumer finance products. Tim has led business development and marketing in start-up environments and has planned, launched, fundraised for and operated a start-up technology business.
Prior to co-founding Huron River Ventures, Tim co-led HSBC Card Services’ New Products group as well as its Corporate Ventures group focused on business services, financial technology, and digital marketing. In his New Products role, he co-founded and operated a first-of-its-kind consumer payment and affinity loyalty business including forming and leading the business development, marketing, and program management teams. Prior to joining the venture community, Tim spent 5 years in capital markets and mergers & acquisitions at J.P. Morgan in Chicago, executing dozens of transactions valued in excess of $10 billion.
Richard Stuebi — Early Stage Partners LP
Richard leads Advanced Energy & Cleantech investments at Early Stage Partners. Richard’s focus is on identifying capital efficient companies in a field with many capital-intensive technologies under development. Richard joined Early Stage Partners as Managing Director in September, 2009. He has over 20 years of experience as an executive, entrepreneur and consultant in the energy industry, with wide knowledge of energy sector participants, activities, economics and regulations, and strong business perspectives on the energy sector’s likely evolution.
Richard is also the non-resident Fellow for Energy and Environmental Advancement at The Cleveland Foundation, where he has been an active force in building an advanced energy cluster in the Cleveland area. Before coming to Ohio, Richard founded Denver-based NextWave Energy in 1999, assisting clients with new energy businesses or technologies in business development, strategy and capital formation. Reflecting NextWave Energy’s entrepreneurial interests, Richard participated in the founding and management of several energy-related ventures. Prior to founding NextWave Energy, Richard was a Senior Vice President at global commodity trading firm Louis Dreyfus, where he was responsible for North American electric and gas business development activities.
Richard previously was a management consultant for 6 years at McKinsey & Co., assisting clients in developing strategies and enhancing organizational capabilities to prepare for electricity sector deregulation and restructuring. He worked for extended periods with two of the five largest U.S. electric utilities and aided several other electric utilities, large energy consumers, fuel suppliers, and independent power producers.
Richard has degrees in Economics from the Massachusetts Institute of Technology (B.S) and Stanford University (M.S.).
Jason Townsend — Resonant Venture Partners
Jason is a Managing Director and Founder of Resonant Venture Partners. He has over twelve years of experience in the semiconductor, software, clean tech, automotive, and real estate industries. Jason has been an active investor for over eight years and was recently named to the Crain’s Detroit Business 2010 “40 Under 40” List.
Before Resonant, Jason served as a managing director of the student advisory board and deal team leader of the $5.5M Wolverine Venture Fund at the Ross School of Business. For 7 years prior to Ross, Jason worked at Intel and was the youngest founding member of the Corporate Business Development Management team where he sold Intel silicon into a variety of technology sectors. In addition to his corporate experience, Jason is an entrepreneur at heart, having served as CEO for three startup companies.
Tucker Twitmyer — EnerTech Capital
Tucker has been investing in energy and clean energy companies and projects for 10 years. Tucker covers the alternative energy (solar, wind, and algal fuel), oil and gas, and smart grid and energy efficiency sectors.
Prior to EnerTech, Tucker was a co-founder and Managing Director of Katalyst LLC, a private equity services firm and a Senior Manager at Andersen Consulting, now Accenture. Tucker began his career in finance and IT operations with MultiServ, a provider of material handling and recycling services to the steel industry.
Tucker currently sits on the boards of OwnEnergy and Tangent Energy Solutions. He previously sat on the boards of Enerwise and FuelQuest and was an observer to Comverge and Altela. He is a member of the CleanTech Venture Network Advisory Board and former co-President of Wharton Private Equity Partners.
Tucker received a BA in Political Science from the University of Pennsylvania and an MBA from the Wharton School of the University of Pennsylvania.
Sonali Vijayavargiya — Augment Ventures
Sonali launched Augment Ventures in January of 2011, and brings in over sixteen years of experience in Project Finance, Investment Banking and Venture Investing. She works closely with early stage companies, nurturing and developing them from proof of concept to final IPO or strategic sale. She has advised entrepreneurs and technologists in a number of different industries: Alternative Energy, Information Technology, Automotive and Life Sciences. Her perceptive insight into technologies and business models for early stage companies has helped shape commercial success for her clients. Sonali’s global work experience has given her a keen eye for leveraging economic and regional efficiencies to develop profitable cross border alliances among companies operating in different sectors.
Prior to Augment Ventures, in 2005, Sonali founded Augment Capital LLC, a venture advisory practice, where she provided strategic advice to many seed and early stage companies in CleanTech and Information Technology. Through Augment Capital, she successfully helped her clients position their start-ups to secure over $20 million dollars in funding. These companies have further raised an additional $60 million in follow-on funding through national and international venture funds. Some of her successful clients include: Accuri Cytometers, AMI, Danotek Motion Technologies, Global Energy Conversion and NRG Dynamix.
She holds an M.B.A. from the Symbiosis Institute of Business Management and a Bachelor of Science in Statistics from Fergusson College both in Pune, India. She is a recipient of Leaders and Innovators award by Grant Thornton (2008), Corp! Entrepreneur of Distinction Award (2011) and Top 10 Michigan Business Women awarded by The Greater Detroit chapter of National Association of Women Business Owners (2012). Currently, she serves as an advisor to Frankel Fund, a pre-seed fund run students at University of Michigan Ross Business School.
Jody Vanderwel — Grand Angels
Jody is President of Grand Angels and has served in that role since 2005. After several years in private legal practice, she was Corporate Counsel and then Vice President for Corporate Giving at Herman Miller, Inc. She is currently a member of the Michigan Venture Capital Association Board, the Michigan Accelerator Fund I Advisory Board, and the Fuller Theological Seminary Board. She also chairs the Board of Priority Health. Her past board service includes the Grand Rapids Symphony, Holland Symphony, and Young Life National Board. Jody holds a B.A. degree from the University of Colorado and a J.D. degree from Washington University in St. Louis.